NBIX logo

Neurocrine Biosciences, Inc. (NBIX) Total Expenses

Annual Total Expenses:

$1.77B+$280.00M(+18.76%)
December 31, 2024

Summary

  • As of today, NBIX annual total expenses is $1.77 billion, with the most recent change of +$280.00 million (+18.76%) on December 31, 2024.
  • During the last 3 years, NBIX annual total expenses has risen by +$846.60 million (+91.46%).
  • NBIX annual total expenses is now at all-time high.

Performance

NBIX Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXincome statement metrics

Quarterly Total Expenses:

$585.40M+$5.40M(+0.93%)
September 30, 2025

Summary

  • As of today, NBIX quarterly total expenses is $585.40 million, with the most recent change of +$5.40 million (+0.93%) on September 30, 2025.
  • Over the past year, NBIX quarterly total expenses has increased by +$93.10 million (+18.91%).
  • NBIX quarterly total expenses is now at all-time high.

Performance

NBIX Quarterly Total Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXincome statement metrics

Total Expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

NBIX Total Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+18.8%+18.9%
3Y3 Years+91.5%+83.3%
5Y5 Years+215.6%+85.2%

NBIX Total Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+91.5%at high+83.3%
5Y5-Yearat high+215.6%at high+685.4%
All-TimeAll-Timeat high>+9999.0%at high+685.4%

NBIX Total Expenses History

DateAnnualQuarterly
Sep 2025
-
$585.40M(+0.9%)
Jun 2025
-
$580.00M(+2.7%)
Mar 2025
-
$564.70M(+7.6%)
Dec 2024
$1.77B(+18.8%)
$524.60M(+6.6%)
Sep 2024
-
$492.30M(-6.3%)
Jun 2024
-
$525.20M(+11.3%)
Mar 2024
-
$471.90M(+28.4%)
Dec 2023
$1.49B(+20.4%)
$367.50M(-11.6%)
Sep 2023
-
$415.70M(+16.4%)
Jun 2023
-
$357.20M(-28.1%)
Mar 2023
-
$497.00M(+53.9%)
Dec 2022
$1.24B(+33.9%)
$323.00M(+1.1%)
Sep 2022
-
$319.40M(-19.2%)
Jun 2022
-
$395.10M(+33.2%)
Mar 2022
-
$296.70M(-7.1%)
Dec 2021
$925.70M(+28.9%)
$319.30M(+16.7%)
Sep 2021
-
$273.50M(+10.9%)
Jun 2021
-
$246.60M(+20.6%)
Mar 2021
-
$204.50M(+304.5%)
Dec 2020
$718.40M(+27.9%)
-$100.00M(-131.6%)
Sep 2020
-
$316.10M(+41.9%)
Jun 2020
-
$222.80M(+11.6%)
Mar 2020
-
$199.70M(-5.0%)
Dec 2019
$561.50M(+37.1%)
$210.10M(+24.8%)
Sep 2019
-
$168.31M(+27.3%)
Jun 2019
-
$132.24M(-45.0%)
Mar 2019
-
$240.52M(+112.1%)
Dec 2018
$409.60M(+55.7%)
$113.41M(+12.3%)
Sep 2018
-
$100.99M(-1.8%)
Jun 2018
-
$102.82M(-8.9%)
Mar 2018
-
$112.90M(+28.9%)
Dec 2017
$262.99M(+62.0%)
$87.62M(+21.9%)
Sep 2017
-
$71.90M(+8.4%)
Jun 2017
-
$66.32M(-15.3%)
Mar 2017
-
$78.33M(+75.4%)
Dec 2016
$162.37M(+42.5%)
$44.66M(+21.1%)
Sep 2016
-
$36.89M(-8.4%)
Jun 2016
-
$40.28M(+17.6%)
Mar 2016
-
$34.26M(+16.9%)
Dec 2015
$113.97M(+76.9%)
$29.32M(-14.9%)
Sep 2015
-
$34.44M(+43.6%)
Jun 2015
-
$23.99M(+14.4%)
Mar 2015
-
$20.96M(+7.8%)
Dec 2014
$64.41M(+22.5%)
$19.44M(+22.5%)
Sep 2014
-
$15.88M(+18.6%)
Jun 2014
-
$13.38M(+13.0%)
Mar 2014
-
$11.84M(+4.1%)
Dec 2013
$52.60M(+1.8%)
$11.37M(-4.1%)
Sep 2013
-
$11.86M(-8.6%)
Jun 2013
-
$12.97M(+1.3%)
Mar 2013
-
$12.80M(+2.8%)
Dec 2012
$51.69M(+18.9%)
$12.46M(+0.2%)
Sep 2012
-
$12.44M(+12.3%)
Jun 2012
-
$11.07M(-8.9%)
Mar 2012
-
$12.15M(+24.3%)
Dec 2011
$43.49M(-7.9%)
$9.78M(-4.6%)
Sep 2011
-
$10.25M(+0.7%)
Jun 2011
-
$10.18M(+5.7%)
Mar 2011
-
$9.63M(-13.8%)
DateAnnualQuarterly
Dec 2010
$47.22M(-12.7%)
$11.17M(+0.5%)
Sep 2010
-
$11.12M(+13.5%)
Jun 2010
-
$9.79M(+4.3%)
Mar 2010
-
$9.39M(+8.5%)
Dec 2009
$54.07M(-39.4%)
$8.66M(-2.9%)
Sep 2009
-
$8.91M(-44.4%)
Jun 2009
-
$16.01M(-21.6%)
Mar 2009
-
$20.41M(-31.0%)
Dec 2008
$89.22M(-58.2%)
$29.58M(+60.2%)
Sep 2008
-
$18.47M(-14.9%)
Jun 2008
-
$21.70M(-4.9%)
Mar 2008
-
$22.83M(-82.2%)
Dec 2007
$213.47M(+39.9%)
$128.51M(+362.6%)
Sep 2007
-
$27.78M(+5.2%)
Jun 2007
-
$26.41M(+2.3%)
Mar 2007
-
$25.82M(+6.9%)
Dec 2006
$152.55M(+2.4%)
$24.15M(-39.9%)
Sep 2006
-
$40.22M(+9.6%)
Jun 2006
-
$36.69M(-19.1%)
Mar 2006
-
$45.38M(+19.4%)
Dec 2005
$148.96M(+8.3%)
$38.02M(-1.5%)
Sep 2005
-
$38.59M(-0.5%)
Jun 2005
-
$38.77M(+26.3%)
Mar 2005
-
$30.69M(-21.5%)
Dec 2004
$137.51M(-30.5%)
$39.10M(+7.6%)
Sep 2004
-
$36.35M(+38.8%)
Jun 2004
-
$26.18M(-10.7%)
Mar 2004
-
$29.32M(+22.5%)
Dec 2003
$197.87M(+62.6%)
$23.94M(-38.8%)
Sep 2003
-
$39.09M(-29.2%)
Jun 2003
-
$55.19M(+8.0%)
Mar 2003
-
$51.11M(+19.8%)
Dec 2002
$121.66M(+42.9%)
$42.66M(+69.2%)
Sep 2002
-
$25.22M(+5.2%)
Jun 2002
-
$23.98M(+15.7%)
Mar 2002
-
$20.72M(-24.5%)
Dec 2001
$85.12M(+69.6%)
$27.44M(+43.8%)
Sep 2001
-
$19.09M(+14.5%)
Jun 2001
-
$16.67M(+11.5%)
Mar 2001
-
$14.95M(+15.2%)
Dec 2000
$50.19M(+36.8%)
$12.98M(-3.6%)
Sep 2000
-
$13.46M(+65.5%)
Jun 2000
-
$8.13M(-7.8%)
Mar 2000
-
$8.82M(+11.9%)
Dec 1999
$36.70M(+29.2%)
$7.89M(-18.2%)
Sep 1999
-
$9.64M(+14.1%)
Jun 1999
-
$8.45M(+10.6%)
Mar 1999
-
$7.64M(-32.5%)
Dec 1998
$28.40M(+10.9%)
$11.31M(+24.4%)
Sep 1998
-
$9.09M(-11.5%)
Jun 1998
-
$10.27M(+92.9%)
Mar 1998
-
$5.32M(-29.0%)
Dec 1997
$25.60M(+57.1%)
$7.50M(+13.6%)
Sep 1997
-
$6.60M(+15.8%)
Jun 1997
-
$5.70M(0.0%)
Mar 1997
-
$5.70M(-5.0%)
Dec 1996
$16.30M
$6.00M(+62.2%)
Sep 1996
-
$3.70M(-11.9%)
Jun 1996
-
$4.20M(+75.0%)
Mar 1996
-
$2.40M

FAQ

  • What is Neurocrine Biosciences, Inc. annual total expenses?
  • What is the all-time high annual total expenses for Neurocrine Biosciences, Inc.?
  • What is Neurocrine Biosciences, Inc. annual total expenses year-on-year change?
  • What is Neurocrine Biosciences, Inc. quarterly total expenses?
  • What is the all-time high quarterly total expenses for Neurocrine Biosciences, Inc.?
  • What is Neurocrine Biosciences, Inc. quarterly total expenses year-on-year change?

What is Neurocrine Biosciences, Inc. annual total expenses?

The current annual total expenses of NBIX is $1.77B

What is the all-time high annual total expenses for Neurocrine Biosciences, Inc.?

Neurocrine Biosciences, Inc. all-time high annual total expenses is $1.77B

What is Neurocrine Biosciences, Inc. annual total expenses year-on-year change?

Over the past year, NBIX annual total expenses has changed by +$280.00M (+18.76%)

What is Neurocrine Biosciences, Inc. quarterly total expenses?

The current quarterly total expenses of NBIX is $585.40M

What is the all-time high quarterly total expenses for Neurocrine Biosciences, Inc.?

Neurocrine Biosciences, Inc. all-time high quarterly total expenses is $585.40M

What is Neurocrine Biosciences, Inc. quarterly total expenses year-on-year change?

Over the past year, NBIX quarterly total expenses has changed by +$93.10M (+18.91%)
On this page